AHIP Examines the High Cost of Oncology Drugs
Every American deserves access to affordable, high-quality care and health coverage -- and that includes getting the medications they need at a cost they can afford. But drug prices are out of control - with Big Pharma alone controlling the price. The problem of the price is particularly acute for patients who are fighting cancer.
Cancer patients rely on innovative, highly effective prescription drugs, yet rising drug costs are potentially shutting the door to these life-saving treatments. A recent AHIP blog examined how oncology drug costs have been accelerating over the past few years. Median annual oncology drug spending per Medicare Part B patient, for example, increased from
Big Pharma argues that high drug prices are necessary to cover the increasing costs of drug development; yet a recent AHIP analysis found that pharmaceutical companies spend more of their money on marketing and administrative expenses than on research and development. As drug costs continue to eat up more of hardworking Americans' premiums, we must work together to lower drug prices to improve health care affordability and access for everyone.
We should not have to choose between affordability and innovation when it comes to prescription drugs. With the right solutions and genuine collaboration, we can achieve both.
* * *
JOURNAL:
* * *
Original text here: https://www.ahip.org/news/press-releases/ahip-examines-the-high-cost-of-oncology-drugs


PGIM Quantitative Solutions Bolsters Distribution Team With Senior Appointment and Promotion
Geneva Association: Population Aging Is Social, Economic Opportunity
Advisor News
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
More Advisor NewsAnnuity News
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
- Annuities to play a larger role in workplace retirement plans
- FHLBank Pittsburgh Announces Results in 2026 Board Election
More Annuity NewsHealth/Employee Benefits News
- Health insurers leave Ohio marketplace
- Rising hospital, drug costs boost health insurance premiums at fastest pace since start of Obamacare
- Patients with 3 health insurance plans lose access to Miami health network
- Weld County deputy struggling after being injured by DUI driver (photo gallery)
- Changes to Medicare Advantage plan offerings affect Montana seniors
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
- Military Briefs: November 12-18
- Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
More Life Insurance News